Alexey Strygin

Chief Digital Health Officer at Gero

Alexey is longevity executive and bioentrepreneur, currently serving as Chief Digital Health Officer at Gero.ai. Previously, Alexey served as co-founder and CEO of Gray Matter, which developed therapeutic peptides solving age-related cognitive decline and longevity; CEO of Cryno Biotech, a company developing a novel GLP-1 agonist; and was an early team member of two longevity companies - Insilico Medicine and Centaura.

Articles

The Impact of Scientific Advisory Boards on Longevity Biotech Startups: Opportunities and Challenges

Exploring the formation, purpose, and advantages of SABs within the context of longevity biotech startups.